Datasets
Buyer room
PHESI.COMManage supplier listing
Phesi — Aggregated clinical trial protocol and patient-outcomes intelligence ('Trial Accelerator' platform) built from contextualized data spanning 375 million patients across 232 countries, drawn from 719,183 studies and 22 registries, plus analysis of 600,000+ clinical trial protocols linking protocol design to real patient population/outcomes data.. 12 employees (Apollo); contextualized data spanning 375M patients, 232 countries, 719,183 studies, and 22 registries, with 600,000+ clinical trial protocols analyzed (stated on page).. Use cases: Clinical trial protocol design optimization, pat…
Aggregated clinical trial protocol and patient-outcomes intelligence ('Trial Accelerator' platform) built from contextualized data spanning 375 million patients across 232 countries, drawn from 719,183 studies and 22 registries, plus analysis of 600,000+ clinical trial protocols linking protocol design to real patient population/outcomes data.
Scale 375 million patientsFrom 15 yearsCoverage Health Care
Sample, licence terms, pricing and eval results when Phesi publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →What buyers ask about Phesi, answered from this page.
Phesi — Aggregated clinical trial protocol and patient-outcomes intelligence ('Trial Accelerator' platform) built from contextualized data spanning 375 million patients across 232 countries, drawn from 719,183 studies and 22 registries, plus analysis of 600,000+ clinical trial protocols linking protocol design to real patient population/outcomes data.. 12 employees (Apollo); contextualized data spanning 375M patients, 232 countries, 719,183 studies, and 22 registries, with 600,000+ clinical trial protocols analyzed (stated on page).. Use cases: Clinical trial protocol design optimization, pat…
Phesi offers (Alternative) — 375 million patients, 232 countries, 719,183 studies, 22 registries, and 600,000+ clinical trial protocols analyzed (all explicitly stated on the page)..
Clinical trial protocol design optimization, patient-population/outcomes benchmarking, AI-driven trial design validation, recruitment-risk and amendment-risk prediction, biopharma R&D strategy.
The data is with 15 years of history.
Coverage spans US; Life Sciences Tools & Services; alternative; equities.
Phesi has not added their own details yet. Not yet on file: